Search Results - "Doad, Gurinderpal"

Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States by Farber, Harrison W., Germack, Hayley D., Croteau, Nicole S., Simeone, Jason C., Tang, Fei, Paoli, Carly J., Doad, Gurinderpal, Panjabi, Sumeet, De Marco, Teresa

“…Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication…”
Get full text

REAL-WORLD ASSOCIATION BETWEEN NONADHERENCE TO PULMONARY ARTERIAL HYPERTENSION MEDICATIONS AND CLINICAL OUTCOMES IN THE US by FARBER, HARRISON, GERMACK, HAYLEY, CROTEAU, NICOLE, SIMEONE, JASON, TANG, FEI, WORDEN, CARLY, DOAD, GURINDERPAL, PANJABI, SUMEET, DE MARCO, TERESA

Get full text

934: UTILIZING THE CARBAPENEM-VALPROIC ACID DRUG INTERACTION IN THE MANAGEMENT OF VALPROIC ACID OVERDOSE by Doad, Gurinderpal, McManus, Dayna, Topal, Jeffrey, Lopez, Felipe

Get full text

CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND SELF-REPORTED MENTAL HEALTH COMORBIDITIES IN SPHERE (SELEXIPAG: THE USERS DRUG REGISTRY) by MCLAUGHLIN, VALLERIE, FARBER, HARRISON W, HIGHLAND, KRISTIN B, KIM, NICK H, CHAKINALA, MURALI M, CHIN, KELLY, HAN, MICHELLE, DOAD, GURINDERPAL, STRACHAN, PAUL M, CHO, MICHELLE, TOBORE, TOBORE, RAHMAN, MOHAMMAD, HEMNES, ANNA R

Get full text

CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TRANSITIONING TO SELEXIPAG FROM ANOTHER PROSTACYCLIN PATHWAY AGENT IN THE SPHERE REGISTRY by CHAKINALA, MURALI M, MCLAUGHLIN, VALLERIE, FARBER, HARRISON W, HIGHLAND, KRISTIN B, HEMNES, ANNA R, CHIN, KELLY, HAN, MICHELLE, DOAD, GURINDERPAL, STRACHAN, PAUL M, CHO, MICHELLE, TOBORE, TOBORE, RAHMAN, MOHAMMAD, KIM, NICK H

Get full text

CHARACTERISTICS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION RECEIVING SELEXIPAG IN THE SPHERE REGISTRY BY RACE AND ETHNICITY by FARBER, HARRISON, CHAKINALA, MURALI M, HEMNES, ANNA R, CHIN, KELLY, HIGHLAND, KRISTIN B, MCLAUGHLIN, VALLERIE, MELENDRES-GROVES, LANA, CHO, MICHELLE, DOAD, GURINDERPAL, FATEHI, ELHAM, HAN, MICHELLE, RAHMAN, MOHAMMAD, STRACHAN, PAUL M, TOBORE, TOBORE, KIM, NICK H

Get full text

936: IMPACT OF HIGHER PHENOBARBITAL DOSING ON BENZODIAZEPINE USE IN SEVERE ALCOHOL WITHDRAWAL SYNDROME by Kassab, Hagar, Rouse, Ginger, Webb, Andrew, Murphy, Matthew, Fajardo, Elaine, Doad, Gurinderpal

Get full text

Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study by Benza, Raymond L., Chin, Kelly M., Gaine, Sean, Galiè, Nazzareno, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Sitbon, Olivier, Doad, Gurinderpal, Yen, Joseph, Tang, Xiaoqin, Tapson, Victor

“…Mortality risk assessment informs clinical management of pulmonary arterial hypertension (PAH). The Registry to Evaluate Early and Long-Term PAH Disease…”
Get full text

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review by Burger, Charles D, Tsang, Yuen, Chivers, Marie, Vekaria, Riya Vijay, Doad, Gurinderpal, Atkins, Nikki, Panjabi, Sumeet

“…Pulmonary arterial hypertension (PAH) is a rare and progressive pulmonary vascular disease that can result in right heart failure and death. Oral prostacyclins…”
Get full text

EXPERT CONSENSUS EXPLORING THE DEFINITION OF A DISEASE-MODIFYING THERAPY, AND THE DATA REQUIRED TO ESTABLISH A THERAPY AS DISEASE-MODIFYING IN PULMONARY ARTERIAL HYPERTENSION by MCLAUGHLIN, VALLERIE, FRANTZ, ROBERT P, HEMNES, ANNA R, RAHAGHI, FRANCK, SAHAY, SANDEEP, STRACHAN, PAUL M, LOPEZ, DAVID, LAM, JENNY, CHO, MICHELLE, STONE, MEDI, BRIDGE, DAISY, PERRY, RICHARD, ENSTONE, ASHLEY, PERRETT, LISA, SMITH, HOLLY, DOAD, GURINDERPAL

Get full text